Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients
A first-in-human clinical trial for a mutant KRAS vaccine shows promise in preventing pancreatic cancer among high-risk patients.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Early data from a Phase 1 clinical trial indicates that an mKRAS vaccine is capable of preventing pancreatic cancer in high-risk individuals. The treatment has been shown to elicit durable T-cell responses in patients with pancreatic ductal adenocarcinoma (PDAC).
Coverage from Fox News, The Scientist, Oncodaily, and CancerNetwork emphasizes that these first-in-human results are encouraging. Anna Berkenblit is cited in reports regarding the early data of the mutant KRAS vaccine.
Future focus remains on the progression of the vaccine's efficacy following these initial Phase 1 trial results.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 40m ago.
Quick answers
What is the name of the vaccine being tested?
The vaccine is referred to as the mKRAS vaccine.
What stage of testing is the vaccine currently in?
The vaccine has shown promise in a Phase 1 clinical trial.
Who is the target group for this vaccine?
The vaccine is designed for high-risk patients to prevent the onset of pancreatic cancer.
Coverage (4)
- First-in-Human mKRAS Vaccine Elicits Durable T-Cell Responses in High-Risk PDAC CancerNetwork · 4h ago
- Anna Berkenblit: An Encouraging Early Data on a Mutant KRAS Vaccine to Prevent Pancreatic Cancer Oncodaily · 4h ago
- A Pancreatic Cancer Vaccine Shows Promise in a Phase 1 Clinical Trial the-scientist.com · 4h ago
- Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients Fox News · 4h ago broke it first
People, places & organizations
Topics
Related trends
Johns Hopkins surgeon highlights AI breakthrough that could spot pancreatic cancer before doctors
A Johns Hopkins surgeon is highlighting an AI breakthrough capable of detecting pancreatic cancer before physicians can.
Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
10 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread
Ozempic and similar drugs being explored for potential cancer prevention benefits
A breakthrough in pancreatic cancer has experts excited
7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Can 2 drugs work better than 1 against Alzheimer’s? UCSF aims to find out
UCSF has begun screening patients for a novel trial testing whether a combination of two drugs is more effective against Alzheimer's than a single treatment.